NMO-IgG
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury
10
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis
9
Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
10
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
15
A new M23-based ELISA assay for anti-aquaporin 4 autoantibodies: diagnostic accuracy and clinical correlation
7
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG
15
The role of anti aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica
9
Evidence-based guideline: Clinical evaluation and treatment of transverse myelitisReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
8
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica
12
Update on neuromyelitis optica: natural history and management
15
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
5
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate
7
Human leukocyte antigens‑immunogenetics of neuromyelitis optica or Devic’s disease and the impact on the immunopathogenesis, diagnosis and treatment: a critical review
7
Nemo is an inducible antagonist of Wingless signaling during Drosophila wing development
10
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
16
MRI characteristics of neuromyelitis optica spectrum disorderAn international update
11
IgG Charge
14
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
45
Epstein Barr Virus Antibodies in Kawasaki Disease
5
IgG glycoforms in arthritis
217